Editas Medicine Stock (NASDAQ: EDIT) stock price, news, charts, stock research, profile.
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Korro Bio (NASDAQ:KRRO) and PepGen (NASDAQ:PEPG).
Editas Medicine has a consensus price target of $14.05.
The stock price for Editas Medicine (NASDAQ: EDIT) is $3.54 last updated September 24, 2024 at 7:36 PM EDT.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.